At k = 10, the genes screened in this study were CDK4, CDKN2B, TP53, NF1, FGFRCDKN2A, TP53, PRF1, RB1, and SIGLEC9, and the enriched pathways were Glioma and Cell Cycle. Here, SIGLEC9 is linked to glioma.